2026³â 02¿ù 16ÀÏ ¿ù¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Airgain Launches Its First Integrated Artificial Intelligence AT-Flight Asset Tracking Solution

Airgain¡¯s AT-Flight Asset Tracker device is cellular enabled and in-flight certified to allow for full journey tracking
´º½ºÀÏÀÚ: 2024-11-21


Airgain has released its AT-Flight asset tracker for real-time tracking across ground and air transportation. (Photo: Airgain)

SAN DIEGO -- Airgain, Inc. (NASDAQ: AIRG), a leading provider of wireless connectivity solutions, has released the AT-Flight asset tracker, targeting the healthcare and life sciences IoT markets.

Designed for high-value, temperature-sensitive assets, the AT-Flight offers an ideal solution for real-time tracking across ground and air transportation, ensuring compliance and operational efficiency in cold chain logistics and other critical healthcare applications.

The AT-Flight combines advanced artificial intelligence with ambient sensor technology to automatically detect a flight event and activate airplane mode to comply with FAA regulations — eliminating the need for manual intervention.

Its impressive battery life exceeds competitors, reducing the need for frequent battery replacements, improving efficiency, and minimizing operating costs, while its flight-approved battery options further enhance its suitability for the unique demands of air transportation. The AT-Flight also boasts a wide operating temperature range, capable of tracking assets in environments as cold as -20°C, making it perfectly suited for transporting temperature-sensitive medical goods like vaccines and pharmaceuticals.

By launching the AT-Flight, Airgain is well-positioned to meet the increasing demand for high-value asset tracking solutions in the healthcare and life sciences sector, which are expected to grow by 13% annually through 2030. The AT-Flight has received PTCRB, FCC, and DO-160 certifications, and Airgain is actively pursuing approvals with leading U.S. and European airlines.

This product launch is an integral component of Airgain’s comprehensive strategy to expand its presence in high-value IoT markets by offering a diverse portfolio of innovative and high-performing tracking solutions. As Airgain continues to develop IoT products for specific sectors, we aim to expand our product portfolio to meet the needs of specific applications.

Joe Porrazzo, Director of Product Line Management for Industrial IoT at Airgain, said:

“Automatic flight detection in the AT-Flight is a great opportunity for Airgain asset trackers to simplify the user experience while ensuring compliance with airline industry requirements and best practices. I am also pleased to announce that we have already received the initial purchase order from a leading healthcare solution provider, and we will begin volume shipments of AT-Flight units in Q1 2025.”

Airgain’s family of Asset Trackers use a range of location services, including GPS and real-time cellular and Wi-Fi triangulation. With a variety of customizable options, Airgain asset trackers allow customers to easily find the ideal configuration tailored to their specific business needs.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Rimini Street Earns Industry Honors for AI Innovation, Client Focus, Technical Excellence and Business Impact
Lenovo Brings Real-Time Store Visibility and AI-Driven Support to Retail—Delivering Value on Day One
Blue Shift Report Highlights Systemic Vulnerabilities Caused by the Hidden Cost of AI
Australian Defence Force Secures Satellite Communications on SES IS-22
BlueMatrix and Perplexity Partner to Bring AI-Powered Discovery to Institutional Research
KIOXIA SSDs Achieve Compatibility with Microchip¡¯s Adaptec¢ç SmartRAID 4300 Series RAID Storage Accelerator
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor

 

ACCELQ Crowned Leader and Customer Favorite in The Forrester Wave¢â fo...
Rigaku Launches ONYX 3200, a Metrology Instrument for Semiconductor Ma...
IntelliVIX Showcases ¡®K-AI¡¯ Prowess at CES 2026, Accelerating Global...
BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J...
Interactive Brokers Redesigns IBKR GlobalTrader App for Simpler, Smart...
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of M...
Biocytogen, Acepodia Expand Collaboration on Option-Based Framework fo...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..